BIO: Bio-Rad Laboratories, Inc. - Summary | Jitta

Bio-Rad Laboratories, Inc.

NYSE:BIO

Price
$705.98
Loss Chance
43.2%
6.99JITTA SCORE
142.42%Over Jitta Line
Jitta Ranking
46 / 1,042
793 / 4,597
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (71)
Recent Business Performance (98)
Financial Strength (96)
Return to Shareholders (7)
Competitive Advantage (62)
Jitta Signs
Revenue and EarningConsistent
Recent Business PerformanceEarning Growth Last Year
Operating MarginExpansion
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
SG&A to SalesDecreasing Every Year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.99
142.42%
2.24
353.92%
Life Sciences Tools and Services
7.15
148.21%
5.51
12.63%
6.52
77.54%
COMPANY DESCRIPTION
Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.